Antithrombotic Strategies in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention

Area of Science:

• Cardiology
• Pharmacology
• Clinical Medicine

Background:

• Atrial fibrillation (AF) patients undergoing percutaneous coronary intervention (PCI) present a complex therapeutic challenge.
• Balancing the prevention of thrombotic events (stroke, ischemia) against bleeding complications is critical.

Purpose of the Study:

• To review current risk stratification schemes for stroke and bleeding in AF patients undergoing PCI.
• To discuss optimal oral antiplatelet and anticoagulation regimens.
• To summarize evidence and recommendations for long-term antithrombotic therapy post-PCI in AF patients.

Main Methods:

• Literature review of randomized trials and clinical guidelines.
• Analysis of risk stratification tools for thrombotic and bleeding events.
• Synthesis of evidence on dual and triple antithrombotic therapy strategies.

Main Results:

• Limited high-powered randomized trial data exists for definitive strategy recommendations.
• Current guidelines offer restricted guidance due to insufficient evidence.
• Risk assessment tools for both thrombosis and bleeding are essential for individualized treatment.

Conclusions:

• The optimal antithrombotic strategy for AF patients undergoing PCI requires further research.
• Personalized treatment decisions must integrate both thrombotic and bleeding risk assessments.
• Future studies should focus on powerful randomized trials to guide clinical practice and recommendations.